Counselling framework for moderate-penetrance cancer-susceptibility mutations

@article{Tung2016CounsellingFF,
  title={Counselling framework for moderate-penetrance cancer-susceptibility mutations},
  author={Nadine Tung and Susan Domchek and Zsofia Kinga Stadler and Katherine L Nathanson and Fergus J. Couch and Judy E Garber and Kenneth Offit and Mark E. Robson},
  journal={Nature Reviews Clinical Oncology},
  year={2016},
  volume={13},
  pages={581-588}
}
The use of multigene panels for the assessment of cancer susceptibility is expanding rapidly in clinical practice, particularly in the USA, despite concerns regarding the uncertain clinical validity for some gene variants and the uncertain clinical utility of most multigene panels. So-called 'moderate-penetrance' gene mutations associated with cancer susceptibility are identified in approximately 2–5% of individuals referred for clinical testing; some of these mutations are potentially… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 16 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
39 Citations
62 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 62 references

implications for gene panel testing

  • Easton, D. F. et al. No evidence that protein truncating vari risk
  • J. Med. Genet. http://dx.doi.org/10.1136…
  • 2016

Similar Papers

Loading similar papers…